TraceLink Achieves 69% Overall Revenue Growth in Q1 2018, Including 270% Revenue Growth in EMEA

TraceLink announces financial growth and milestones during the first quarter of 2018, advancing its market share position as the only digital supply chain network for global serialization and track and trace. With serialization and transaction activity on the network growing exponentially, TraceLink is setting the stage for future business transformation with applications that will deliver a new paradigm of real-time digital information sharing across the entire supply chain.

Read Press Release

TraceLink Adds Industry Visionaries to Discuss Machine Learning, AI, Big Data and Patient Engagement at FutureLink Munich

TraceLink announces the latest keynote speakers for FutureLink Munich, including industry and academic thought-leaders: Professor Elgar Fleisch, Ph.D., of ETH Zurich; Justus Wolff of the Syte Institute; and Andrew Rut, M.D., CEO, MyMeds&Me. The speakers will deliver industry insights on how to capitalize on serialization and big data with AI, machine learning and predictive analytics - all to improve patient outcomes. Seats are filling fast - Register now!

TraceLink Publishes 2nd Annual Global Drug Supply, Safety and Traceability Report

The largest survey ever conducted on serialization for life sciences, the 2017 Global Drug Supply, Safety and Traceability Report went beyond industry’s readiness beliefs for serialization, applying analytical insights into the actionable steps that various segments across the supply chain have taken, in order to prepare for serialization.

Get Report

I'm a (select one)

I want to (I want to)

Subscribe to regulatory & serialization updates

Thank you for subscribing!

TraceLink Achieves 69% Overall Revenue Growth in Q1 2018, Including 270% Revenue Growth in EMEA

TraceLink Adds Industry Visionaries to Discuss Machine Learning, AI, Big Data and Patient Engagement at FutureLink Munich

TraceLink Publishes 2nd Annual Global Drug Supply, Safety and Traceability Report

Subscribe to regulatory & serialization updates

Thank you for subscribing!

This content is not available in your selected language. If you would like to proceed to the homepage of your selected language site, please click “Proceed”.

TraceLink Achieves 69% Overall Revenue Growth in Q1 2018, Including 270% Revenue Growth in EMEA

TraceLink Adds Industry Visionaries to Discuss Machine Learning, AI, Big Data and Patient Engagement at FutureLink Munich

TraceLink Publishes 2nd Annual Global Drug Supply, Safety and Traceability Report